These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 36652473)

  • 21. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
    Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.
    Hofmann H; Pyrc K; van der Hoek L; Geier M; Berkhout B; Pöhlmann S
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7988-93. PubMed ID: 15897467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses.
    Otter CJ; Fausto A; Tan LH; Khosla AS; Cohen NA; Weiss SR
    Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2218083120. PubMed ID: 37023127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors.
    Hofmann H; Simmons G; Rennekamp AJ; Chaipan C; Gramberg T; Heck E; Geier M; Wegele A; Marzi A; Bates P; Pöhlmann S
    J Virol; 2006 Sep; 80(17):8639-52. PubMed ID: 16912312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia.
    Lynch SA; Subbarao K; Mahanty S; Barber BE; Roulis EV; van der Hoek L; McCarthy JS; Spann KM
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sero-epidemiology of human coronaviruses in three rural communities in Ghana.
    Owusu M; Sylverken AA; El-Duah P; Acheampong G; Mutocheluh M; Adu-Sarkodie Y
    Pan Afr Med J; 2021; 38():244. PubMed ID: 34104292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodetection assays for the quantification of seasonal common cold coronaviruses OC43, NL63, or 229E infection confirm nirmatrelvir as broad coronavirus inhibitor.
    Weil T; Lawrenz J; Seidel A; Münch J; Müller JA
    Antiviral Res; 2022 Jul; 203():105343. PubMed ID: 35598779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human coronavirus NL63: a clinically important virus?
    Fielding BC
    Future Microbiol; 2011 Feb; 6(2):153-9. PubMed ID: 21366416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of Bat Coronaviruses in Kenya Identifies Relatives of Human Coronaviruses NL63 and 229E and Their Recombination History.
    Tao Y; Shi M; Chommanard C; Queen K; Zhang J; Markotter W; Kuzmin IV; Holmes EC; Tong S
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28077633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.
    Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A
    Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
    Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
    Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms of human coronavirus NL63 infection and replication.
    Castillo G; Mora-Díaz JC; Breuer M; Singh P; Nelli RK; Giménez-Lirola LG
    Virus Res; 2023 Apr; 327():199078. PubMed ID: 36813239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza-like illness symptoms due to endemic human coronavirus reinfections are not influenced by the length of the interval separating reinfections.
    Sechan F; Edridge AWD; van Rijswijk J; Jebbink MF; Deijs M; Bakker M; Matser A; Prins M; van der Hoek L
    Microbiol Spectr; 2024 Mar; 12(3):e0391223. PubMed ID: 38329364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
    Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
    J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human seasonal coronavirus neutralization and COVID-19 severity.
    Wells DA; Cantoni D; Mayora-Neto M; Genova CD; Sampson A; Ferrari M; Carnell G; Nadesalingam A; Smith P; Chan A; Raddi G; Castillo-Olivares J; Baxendale H; Temperton N; Heeney JL
    J Med Virol; 2022 Oct; 94(10):4820-4829. PubMed ID: 35705514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.